Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

1.285 -0.025 (-1.91%)
Streaming Delayed Price Updated: 10:22 AM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ocugen Inc

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Chinese Stocks Alert: Why Are BABA, TCEHY, JD, PDD Stocks Down Today?
Chinese tech stocks are taking a beating on Tuesday as investors worry about additional restrictions from the country's government. 
Via InvestorPlace
Why Ocugen Shares Are Rising
Ocugen Inc (NASDAQ: OCGN) shares are trading higher by 23.8% at $4.28 Tuesday morning after the company announced the FDA lifted its clinical hold on the company's COVID-19 vaccine study in the US. 
Via Benzinga
OCGN Stock Alert: Why Is Ocugen Heating Up Today?
Shares of OCGN stock are flying higher after the FDA lifted its clinical hold on Covaxin, the company's coronavirus drug candidate. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million.... 
Via Benzinga
FDA Lifts Clinical Hold On Ocugen's COVID-19 Vaccine Study In US
The FDA has lifted its clinical hold on Ocugen Inc's (NASDAQ: OCGN) investigational new drug application seeking approval to conduct testing of the COVID-... 
Via Benzinga
Despite an 80% Drop, Ocugen Stock Is Still Too Pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it's best to avoid OCGN stock. 
Via InvestorPlace
Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada
Ocugen Inc (NASDAQ: OCGN) has  
Via Benzinga
Can the Faithful Provide a Lifeline to Ocugen?
While it’s an extremely speculative idea, OCGN stock may receive a lifeline from the faith-based community due to a recent tragedy. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
With the long weekend over it's time to start another week of trading with the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
30 Stocks Moving in Tuesday's Pre-Market Session
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 28.5% to $108.31 in pre-market trading. Just hours after launching on Sunday night in Apple’s App Store, Donald... 
Via Benzinga
Ocugen Stock Finally Sunk to Penny Status, But That Doesn’t Make It a Buy
An interview with Dr. Anthony Fauci about the Covaxin vaccine makes you wonder why investors have any interest in OCGN stock. 
Via InvestorPlace
OCGN Stock Alert: Why Is Ocugen Soaring 10% Today?
Shares of OCGN stock are in the green after Covaxin demonstrated strong protection against the omicron and delta variants. 
Via InvestorPlace
Americans’ Appetite for Vaccine Options Bodes Well for Ocugen
OCGN stock is definitely out of favor on Wall Street, but fresh poll data and an imminent R&D hub acquisition should spur some optimism. 
Via InvestorPlace
Ocugen Stock Is a Fairy Tale in Need of a Happy Ending
If you’re investing in OCGN stock, you have to wonder: how much upside can FDA approval really give this beleaguered name? 
Via InvestorPlace
Novavax Stock Is at Risk Despite Positive Poll Results
A recent poll supports Novavax's Covid treatment in the United States, but the vote on today's NVAX stock price chart warns against buying. 
Via InvestorPlace
Who's Winning - The 'Shorters' Or The 'Squeezers'?
A look at how well the 'squeezers' are doing relative to the 
Via Talk Markets
Two Reasons to Skip Ocugen Stock Despite Some Good News
Ocugen was one of the most explosive stocks on the market, all thanks to its coronavirus vaccine, Covaxin. But don't rush to buy just yet. 
Via InvestorPlace
With No Vaccine Approval, Ocugen Is the Definition of Dead Money
Holding out hope for a Covid vaccine approval that might never come, OCGN stock is too risky while the company has no revenue. 
Via InvestorPlace
3 Biotech Stocks That Could Boom or Bust in Q1
The biotech industry is exploding. Biotech stocks provide lots of opportunities for investors who are taking a risk on the medicine's future. 
Via InvestorPlace
Despite Big Disappointment, There’s Still Potential With Ocugen Stock
As this biotech's stock continues to slide lower in price, risk-tolerant investors may find an opportunity with beaten down OCGN stock. 
Via InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
Gainers Aptorum Group Limited (NASDAQ: APM) shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation... 
Via Benzinga
Novavax Appears to be Running Out of Options
With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an abandon-ship investment at this point. 
Via InvestorPlace
7 Penny Stock Bubbles That Are Bound to Burst
Watch out with these seven penny stocks, a mix of plays that are still flying high, and a few that have already seen their bubble deflate. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
7 Robinhood Stocks You Can Still Buy for Under $5
Although 2021 has been a blistering year for equities, there are still some speculative Robinhood stocks to buy under $5. 
Via InvestorPlace
Looking Into Ocugen Inc's Recent Short Interest
Ocugen Inc's (NASDAQ:OCGN) short percent of float has risen 9.83% since last its last report. The company recently reported that it has 54.30 million shares sold short, which is... 
Via Benzinga
Ocugen-Bharat Biotech Partnered COVID-19 Booster Covaxin Neutralizes Omicron, Delta Variants
Ocugen Inc (NASDAQ: OCGN) and its partner, Bharat Biotech, announced results from a COVID-19 vaccine booster study conducted at Emory University. The data demonstrated sera... 
Via Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On Restricted Coverage For Its Alzheimer's Drug Biogen... 
Via Benzinga
CPNG Stock: Why Are Coupang Shares Getting Clobbered Today?
Coupang (CPNG) stock is falling on Monday despite a lack of news and we're diving into possible reasons why that's happening today. 
Via InvestorPlace
LULU Stock: 6 Reasons Why Lululemon Investors Are Feeling Short of Breath Today
Lululemon Athletica (LULU) stock is taking a beating on Monday after releasing updated expectations for its Q4 2021 earnings report. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.